Browsing by Subject "collaboration"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
Item Open Access Acetabular Paralabral Cyst: An Unusual Cause of Lower Extremity Pain and Paresthesia.(J Orthop Sports Phys Ther, 2016-01) Reiman, Michael P; Hash, Thomas W; Mather, Richard CItem Open Access Resilience Decoded: The Role of Firms, Global Value Chains, and the State in COVID-19 Medical Supplies(California Management Review, 2022-02-01) Gereffi, G; Pananond, P; Pedersen, TThis article examines the impacts of the COVID-19 pandemic on resilience. Resilience is not a one-dimensional concept but has different meanings at the levels of the firm (operational efficiency), the global value chain (appropriate governance), and the nation-state (national security). It illustrates resilience dynamics through lessons from case studies of four medical supply products—rubber gloves, face masks, ventilators, and vaccines. It explores how each adjusted to disruptions caused by the COVID-19 pandemic and presents key strategies that can guide managers and policymakers in building resilience for future supply chain disruptions.Item Open Access Standardization, workforce development and advocacy in cell and gene therapies: a summary of the 2020 Regenerative Medicine InterCHANGE.(Cytotherapy, 2021-10) McNiece, Ian K; Wacker, Kara K; Kurtzberg, Joanne; Warkentin, Phyllis ICell and gene therapy is a promising and disruptive new field of medicine for diseases lacking effective treatments. Collaboration among stakeholders has become critically important as investigators, health care providers, manufacturers, couriers, data registries, regulators and payers all become more invested in the success of this field. Many organizations have collaborated with each other to increase clarity, advocate for improvements and share lessons learned. These efforts appear to be making an impact, although the potential for duplicative efforts could slow progress. The second Regenerative Medicine InterCHANGE, hosted by the Foundation for the Accreditation of Cellular Therapy, took place at the Phacilitate Leaders World/World Stem Cell Summit conference in Miami, Florida, on January 24, 2020. Participants from several organizations outlined needs to advance cell and gene therapies. Efforts to address these include standardization, workforce development and advocacy. This article summarizes the major challenges and opportunities discussed during the InterCHANGE.